Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Redefining ALL classification: toward detecting high-risk ALL and implementing precision medicine
Stephen P. Hunger, Charles G. Mullighan
Blood (2015) Vol. 125, Iss. 26, pp. 3977-3987
Open Access | Times Cited: 267

Showing 1-25 of 267 citing articles:

Acute lymphoblastic leukemia: a comprehensive review and 2017 update
T Terwilliger, Maher Abdul‐Hay
Blood Cancer Journal (2017) Vol. 7, Iss. 6, pp. e577-e577
Open Access | Times Cited: 1092
A causal mechanism for childhood acute lymphoblastic leukaemia
Mel Greaves
Nature reviews. Cancer (2018) Vol. 18, Iss. 8, pp. 471-484
Open Access | Times Cited: 464
CD19 CAR immune pressure induces B-precursor acute lymphoblastic leukaemia lineage switch exposing inherent leukaemic plasticity
Elad Jacoby, Sang M. Nguyen, Thomas J. Fountaine, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 376
Targetable kinase gene fusions in high-risk B-ALL: a study from the Children’s Oncology Group
Shalini C. Reshmi, Richard C. Harvey, Kathryn G. Roberts, et al.
Blood (2017) Vol. 129, Iss. 25, pp. 3352-3361
Open Access | Times Cited: 266
Genomic analyses identify recurrent MEF2D fusions in acute lymphoblastic leukaemia
Zhaohui Gu, Michelle L. Churchman, Kathryn G. Roberts, et al.
Nature Communications (2016) Vol. 7, Iss. 1
Open Access | Times Cited: 258
Philadelphia chromosome–like acute lymphoblastic leukemia
Sarah K. Tasian, Mignon L. Loh, Stephen P. Hunger
Blood (2017) Vol. 130, Iss. 19, pp. 2064-2072
Open Access | Times Cited: 252
IKZF1plusDefines a New Minimal Residual Disease–Dependent Very-Poor Prognostic Profile in Pediatric B-Cell Precursor Acute Lymphoblastic Leukemia
Martin Stanulla, Elif Dağdan, Markéta Žaliová, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 12, pp. 1240-1249
Open Access | Times Cited: 250
Adult Acute Lymphoblastic Leukemia
Shilpa Paul, Hagop M. Kantarjian, Elias Jabbour
Mayo Clinic Proceedings (2016) Vol. 91, Iss. 11, pp. 1645-1666
Open Access | Times Cited: 224
Acute lymphoblastic leukaemia
Luca Pagliaro, Sai‐Juan Chen, Daniel Herranz, et al.
Nature Reviews Disease Primers (2024) Vol. 10, Iss. 1
Closed Access | Times Cited: 44
T cell acute lymphoblastic leukemia (T-ALL): New insights into the cellular origins and infiltration mechanisms common and unique among hematologic malignancies
Eduardo Vadillo, Elisa Dorantes‐Acosta, Rosana Pelayo, et al.
Blood Reviews (2017) Vol. 32, Iss. 1, pp. 36-51
Closed Access | Times Cited: 149
Truncating Erythropoietin Receptor Rearrangements in Acute Lymphoblastic Leukemia
Ilaria Iacobucci, Yongjin Li, Kathryn G. Roberts, et al.
Cancer Cell (2016) Vol. 29, Iss. 2, pp. 186-200
Open Access | Times Cited: 132
Intensified Therapy of Acute Lymphoblastic Leukemia in Adults: Report of the Randomized GRAALL-2005 Clinical Trial
Françoise Huguet, Sylvie Chevret, Thibaut Leguay, et al.
Journal of Clinical Oncology (2018) Vol. 36, Iss. 24, pp. 2514-2523
Open Access | Times Cited: 126
Monitoring of childhood ALL using BCR-ABL1 genomic breakpoints identifies a subgroup with CML-like biology
Lenka Hovorková, Markéta Žaliová, Nicola C. Venn, et al.
Blood (2017) Vol. 129, Iss. 20, pp. 2771-2781
Open Access | Times Cited: 112
IKZF1 deletions in pediatric acute lymphoblastic leukemia: still a poor prognostic marker?
Martin Stanulla, Hélène Cavé, Anthony V. Moorman
Blood (2019) Vol. 135, Iss. 4, pp. 252-260
Open Access | Times Cited: 109
Sex ratio among childhood cancers by single year of age
Lindsay A. Williams, Michaela Richardson, Erin L. Marcotte, et al.
Pediatric Blood & Cancer (2019) Vol. 66, Iss. 6
Open Access | Times Cited: 88
The Physiopathology of T- Cell Acute Lymphoblastic Leukemia: Focus on Molecular Aspects
Bruno Fattizzo, Jéssica Rosa, Juri Alessandro Giannotta, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 74
MOLECULAR PROFILING REVEALS NOVEL GENE FUSIONS AND GENETIC MARKERS FOR REFINED PATIENT STRATIFICATION IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA
Borbála Péterffy, Szilvia Krizsán, Bálint Egyed, et al.
Modern Pathology (2025), pp. 100741-100741
Open Access | Times Cited: 1
Leukaemia 'firsts' in cancer research and treatment
Mel Greaves
Nature reviews. Cancer (2016) Vol. 16, Iss. 3, pp. 163-172
Closed Access | Times Cited: 78
Ph-like acute lymphoblastic leukemia
Thai Hoa Tran, Mignon L. Loh
Hematology (2016) Vol. 2016, Iss. 1, pp. 561-566
Open Access | Times Cited: 76
Impact of cytogenetic abnormalities in adults with Ph-negative B-cell precursor acute lymphoblastic leukemia
Mårina Lafage‐Pochitaloff, Laurence Baranger, Mathilde Hunault, et al.
Blood (2017) Vol. 130, Iss. 16, pp. 1832-1844
Open Access | Times Cited: 70
Targeting sphingolipid metabolism as an approach for combination therapies in haematological malignancies
Alexander C. Lewis, Craig T. Wallington‐Beddoe, Jason A. Powell, et al.
Cell Death Discovery (2018) Vol. 4, Iss. 1
Open Access | Times Cited: 68
PAX5 P80R mutation identifies a novel subtype of B-cell precursor acute lymphoblastic leukemia with favorable outcome
Marie Passet, Nicolas Boissel, François Sigaux, et al.
Blood (2018) Vol. 133, Iss. 3, pp. 280-284
Open Access | Times Cited: 65
PDGFRB mutation and tyrosine kinase inhibitor resistance in Ph-like acute lymphoblastic leukemia
Yingchi Zhang, Yufeng Gao, Hui Zhang, et al.
Blood (2018) Vol. 131, Iss. 20, pp. 2256-2261
Open Access | Times Cited: 61
ETV6-related thrombocytopenia and leukemia predisposition
Jorge Di Paola, Christopher C. Porter
Blood (2019) Vol. 134, Iss. 8, pp. 663-667
Open Access | Times Cited: 59
Outcomes of paediatric patients with B-cell acute lymphocytic leukaemia with ABL-class fusion in the pre-tyrosine-kinase inhibitor era: a multicentre, retrospective, cohort study
Monique L. den Boer, Gunnar Cario, Anthony V. Moorman, et al.
The Lancet Haematology (2020) Vol. 8, Iss. 1, pp. e55-e66
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top